BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 7315413)

  • 21. Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin-F2 alpha-induced activity of the rabbit myometrium.
    Ottesen B; Wagner G; Fahrenkrug J
    Prostaglandins; 1980 Mar; 19(3):427-35. PubMed ID: 7384549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of VIP in the female genital tract.
    Ottesen B; Fahrenkrug J; Wagner G; Ulrichsen H; Einer-Jensen N; Carter AM; Larsen JJ; Stolberg B
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():71-8. PubMed ID: 7227322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non-pregnant rabbit.
    Ottesen B; Fahrenkrug J
    Acta Physiol Scand; 1981 Jun; 112(2):195-201. PubMed ID: 7315413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract.
    Ottesen B
    Am J Obstet Gynecol; 1983 Sep; 147(2):208-24. PubMed ID: 6137145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VIP and autonomic neurotransmission.
    Fahrenkrug J
    Pharmacol Ther; 1989; 41(3):515-34. PubMed ID: 2541454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive intestinal polypeptide and the reproductive system.
    Fahrenkrug J; Ottesen B; Palle C
    Ann N Y Acad Sci; 1988; 527():393-404. PubMed ID: 3291695
    [No Abstract]   [Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.